Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-03-16 @ 2:27 AM
Study NCT ID:
NCT00940602
Status:
COMPLETED
Last Update Posted:
2020-11-23
First Post:
2009-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CICL670A2302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None